Studies have reported that multi-drug resistance of chemotherapy often accompanies activation of PI3K/Akt pathway in various cancers [29, 32–34], thus we determined the phosphorylation levels of PI3K/Akt/mTOR pathway in xenograft tumor lysates. This evidence concerns the gene AKT1 and neoplasm.